Medi Assist Reports Q1 FY27: Revenue Climbs 24.1% as AI Contracts Are Signed and International Platform Expands

Medi Assist Reports Q1 FY27: Revenue Climbs 24.1% as AI Contracts Are Signed and International Platform Expands​

Medi Assist Healthcare Services Limited announced its first-quarter results for Fiscal Year 2027, reporting a 24.1% year-over-year rise in operating revenue. The company highlighted the successful transition of its technology platform from an investment phase to monetization, secured seven AI contracts, and established a structured international business through Mayfair We Care.

The company maintains that its three-horizon strategy is on track: strengthening the India TPA franchise, generating revenue from its burgeoning AI stack, and transitioning the international business into a structured platform. Satish Gidugu, CEO & Whole Time Director, noted that "Paramount integration is at its logical closure," stating that their AI stack has moved from investment to early monetization with seven contracts in place.

Q1 FY27 Financial and Operational Snapshot​

The performance across key metrics shows continued growth in market penetration and revenue generation for the company. The detailed financial summary for Q1 FY27 compared against Q1 FY26 is presented below:

Transforming the India TPA Franchise​

The core engine of Medi Assist remains its India TPA franchise. Group revenue stood at ₹166.0 Cr, marking a 25.5% year-over-year increase, with PUM at ₹8,454 Cr (+29.5% YoY). The group's market share reached 37.6%, up from 33.2%.

In terms of operational status, the company confirmed that Paramount integration is functionally complete, reporting that over 95% of group claims and 80% of retail claims have been migrated to MAtrix. The company targets full migration in Q2 FY27, expecting near-term PHS retention drag to normalize throughout FY27.

The technology platform component has significantly evolved, having completed its planned AI investment of approximately ₹24.5 Cr over the past six quarters. This stack—which includes MAven IDP, MAtrix, and MAgnum—is now available for industry use and is generating revenue. The company reported that seven insurers have signed contracts utilizing the various AI stacks, including outcomes-based agreements where compensation is tied directly to measurable value delivered.

International Growth and Governance Update​

Medi Assist has elevated its international presence through Mayfair We Care, increasing its ownership in the entity to 91.75% following Q1 performance, converting the original seed investment into a majority-owned subsidiary. Nikhil Chopra, previously the Chief Business Officer of Medi Assist Group, has been appointed to lead the international business full-time, signifying a material resource commitment.

In the Thailand market, the company launched its first technology deployment contract on July 1, 2026, onboarding multiple corporations for digital health benefits experiences while MAtrix claims integration is underway.

On the governance front, effective August 8, 2026, Dr. Vikram Jit Singh Chhatwal transitioned from Executive Chairman to Non-Executive, Non-Independent Director and Chairman, aiming to separate board leadership from executive management. Gaurav Bhatnagar was appointed as Chief TPA Officer for Medi Assist TPA, reporting to the CEO, and designated as SMP effective August 8, 2026.

Both the technology and international tracks are currently being self-funded by operating cash flows, with management stating that they expect these areas to deliver meaningful EBITDA margin accretion over time without requiring external capital infusion.

MEDIASSIST Stock Price Movement​

Medi Assist Healthcare Services Limited shares slipped on Friday, closing at ₹364.95 after shedding ₹2.15 or 0.59% from the previous close of ₹367.15. The equity finished trading with a volume of 79,223 shares, settling well above the day's low of ₹364.35 but below the open price of ₹369.20.